Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Politics
Tess Ikonomou

'Transformational': cystic fibrosis drug price slashed

A medicine that costs some cystic fibrosis sufferers up to $250,000 per year is being subsidised. (Lukas Coch/AAP PHOTOS)

People living with rarer types of cystic fibrosis will pay a fraction of the price to access life-changing treatment under an expansion of the Pharmaceutical Benefits Scheme.

The changes will take effect from July, and mean the drug Trikafta will be affordable for patients diagnosed with rarer mutations of the disease, thanks to government subsidies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.